ACIR Southern Europe strengthens partnerships at CPHI Frankfurt 2025

Active presence at Europe’s leading pharmaceutical event

At CPHI Frankfurt 2025, Europe’s premier pharmaceutical exhibition, the ACIR Southern Europe team participated alongside specialists, strategic partners, and representatives from its project offices across Southern Europe.
Over three days, meetings were held with manufacturers, distributors, investment funds, and government institutions, reinforcing ACIR’s role as a bridge between European companies and Eurasian markets.

Cooperation and new partnerships

The event provided an opportunity to share ACIR’s experience in implementing joint projects between Southern Europe and Central Asia, highlighting progress in pharmaceutical manufacturing, biotechnology, and medical equipment production.
ACIR presented cooperation mechanisms available to its partners, including financial tools, insurance support, and technical and commercial assistance, enabling European companies to expand into emerging markets with confidence.

Several concrete agreements were reached with companies aiming to strengthen their presence in Central Asia through local production, technology transfer, and supply of active pharmaceutical ingredients.
Plans were also discussed to expand the European pharmaceutical hub managed by ACIR and extend its partner network to new Mediterranean countries.

Building the Europe–Central Asia bridge

Participation in CPHI Frankfurt 2025 reaffirmed ACIR Southern Europe’s commitment to promoting business and scientific cooperation between Europe and Central Asia.
The event marked a significant milestone in deepening industrial integration between the two regions, uniting innovation, quality, and collaboration as drivers of shared growth.